Stay updated on Hemay808 Clinical Trial: Phase I Study
Sign up to get notified when there's something new on the Hemay808 Clinical Trial: Phase I Study page.

Latest updates to the Hemay808 Clinical Trial: Phase I Study page
- Check5 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and operating status, and the page now shows Revision: v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

- Check12 days agoChange DetectedNew page additions include glossary-related items, FDA-regulated status, and MeSH terms, and a No FEAR Act data entry was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference47%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page, updating the version history.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a dedicated Locations section including Jiangsu, consolidating location details for the study. Removed the separate Jiangsu Locations entry and the HHS Vulnerability Disclosure link; page version updated to v3.3.3.SummaryDifference0.2%

- Check69 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing Revision: v3.3.1. The rest of the page content appears unchanged.SummaryDifference0.1%

- Check76 days agoChange Detected- Page revision updated from v3.2.0 to v3.3.1, reflecting an administrative update; no study details or content were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Hemay808 Clinical Trial: Phase I Study
Enter your email address, and we'll notify you when there's something new on the Hemay808 Clinical Trial: Phase I Study page.